Microbix Biosystems Inc. MBX.TO
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 44.10% | -24.55% | 22.12% | 9.46% | -8,345.14% |
| Total Depreciation and Amortization | 0.86% | 11.78% | -4.67% | -1.37% | 7.78% |
| Total Amortization of Deferred Charges | -- | -- | -1.19% | -- | -- |
| Total Other Non-Cash Items | -4.28% | 0.26% | 14.44% | -5.44% | 10.76% |
| Change in Net Operating Assets | -226.96% | 115.70% | -368.10% | 180.26% | -493.23% |
| Cash from Operations | -50.31% | 87.98% | -3,160.16% | 104.39% | -300.75% |
| Capital Expenditure | 78.68% | -32.82% | -9.11% | 20.40% | 17.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 78.68% | -32.82% | -9.11% | 20.40% | 17.67% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -262.15% | 0.00% | -29.87% | 97.39% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -11.51% | -8.00% | 16.61% | 21.90% | 64.17% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -4.02% | -82.92% | -391.29% | 125.86% | -771.32% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.30% | 67.41% | -25,248.84% | 100.49% | -455.74% |